Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19
Altered expression of methylenetetrahydrofolate reductase modifies response to methotrexate in mice
Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea
Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European–Brazilian schizophrenics
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Advice on the genotyping of CYP2C19: comments on a recent article
Response to the letter to the editor by Rasmussen et al.: ‘Advices on the genotyping of CYP2C19 – comments on a recent article’